Hey all, welcome back to the Real Life Pharmacology podcast. I'm your host, pharmacist, Eric Christensen.

Thank you so much for listening today. As always, go check out Real Life Pharmacology.com.

We got your top 200 study guide, 31 page PDF, absolutely no cost to you, simply an email to get you on our subscription list, and we email you out

when we've got new podcasts and content available. So again, absolutely no cost to you. RealLifepharmacology.

com. Go subscribe and get that free Top 200 study guide. Appreciate the support there, of course, as always.

The drug of the day today is rhinolazine.

Brand name of this medication is Renexa,

and I specifically had somebody reach out

that wanted this drug covered,

and I will certainly oblige.

I can't say it's a drug that I see used really often. I can say it's probably a medication I've maybe seen 10 to 20 times in my career. So very,

very seldom is this medication used.

Its primary use and the only use I've ever seen it used for is chronic anginaum.

It does have the off-label use of ventricular tachycardia.

I've never seen it used for that.

So I really don't have any experience in seeing it for that. But that is a reported off label use. So with that chronic end, you know, that's

obviously what I'm going to focus on most. It is not intended for acute relief. So it's nothing like sublingal nitroglycerin, for example.

So that's first patient education point to remember.

It's not going to generally alleviate quickly an episode of angina or chest pain.

Now, most often for chronic angina,

the drugs that are utilized for kind of chronic management

and reducing angina symptoms over time,

...